We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
How to apply for repayment of import duty and VAT on protective equipment or medical supplies brought into the UK from non-EU countries from 30 January 2020 up to 31 December 2020.
Paper prepared by Imperial College London on different potential vaccine roll out strategies at SAGE 76.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Pandemic flu planning information for England and the devolved administrations, including guidance for organisations and businesses.
On 18 March the Defence Secretary announced new measures to enable armed forces personnel to support public services in response to the coronavirus outbreak.
Working with contract management and accreditation.
Guidance for industry on flexible approaches we are taking on good distribution practices.
A collection of factsheets, updated guidelines and news stories related to DBS and coronavirus.
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
How investigators and sponsors should manage clinical trials during COVID-19
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
Our approach to working with clients and making applications.
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Reducing the impact of future pandemics by making Diagnostics, Therapeutics and Vaccines available within 100 days. A report to the G7 by the pandemic preparedness partnership.
A register of agreements relating to exclusion orders made by powers under paragraph 7 of Schedule 3 to The Competition Act 1998.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.